CRISPR Therapeutics
CRSP
#3102
Rank
S$5.33 B
Marketcap
$62.45
Share price
-1.69%
Change (1 day)
-35.32%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2023 (TTM): -$7.32

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -$7.12. In 2022 the company made an earnings per share (EPS) of -$11.25 a decrease over its 2021 EPS that were of $6.71.

EPS history for CRISPR Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.32-34.98%
2022-$11.25-267.74%
2021$6.71-194.33%
2020-$7.11-576.58%
2019$1.49-132.36%
2018-$4.61100.58%
2017-$2.30159.42%
2016-$0.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.93-58.87%๐Ÿ‡บ๐Ÿ‡ธ USA